AORT Artivion, Inc. Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 8월 7, 2026
$22.31
· 52주 범위 %
· 저점 이상
· 고점까지
$19.1652주 저점
$48.2552주 고점
시가총액 (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
매출 (TTM)
$471M
내 배지
52주 범위
$19–$48
애널리스트 평점
BUY
목표 주가
$42
P/E
-371.8
ROE
-0.73%
순이익률
-0.67%
배지 스트립이 비어 있습니다. 이 페이지의 아무 지표나 고정하세요.
AORT 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$22.31
시가총액 (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
매출 (TTM)
$471M
ROE (TTM)
-0.73%
부채/자본 (MRQ)
0.8
52주 범위
$19–$48
AORT 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
범위
막대
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
주식 분할
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2000년 12월 28일 | 3-for-2 | 정방향 |
| 1996년 7월 1일 | 2-for-1 | 정방향 |
Artivion, Inc. Common Stock 정보 위키백과 회사 개요
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
섹터Health Care
산업Health Care
직원1,800
국가US
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출$441M2016-12-31 → 2025-12-31
EPS$0.212016-12-31 → 2025-12-31
잉여현금흐름$839.0K2016-12-31 → 2025-12-31
순이익률-0.67%2016-12-31 → 2025-12-31
가치 평가 및 비율
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | AORT | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | -371.85년 평균 ≈5.0 | ≈5.0 | · | · | |
| P/S (TTM) | 2.45년 평균 ≈3.0 | ≈3.0 | 3.9 | 저평가 | |
| P/B (MRQ) | 2.55년 평균 ≈3.4 | ≈3.4 | 3.9 | 저평가 | |
| EV / EBITDA | 22.55년 평균 ≈32.6 | ≈32.6 | · | · | |
| 주가 / FCF (TTM) | -122.35년 평균 ≈554.3 | ≈554.3 | · | · | |
| 주가 / 현금 흐름 (TTM) | 26.85년 평균 ≈-54.3 | ≈-54.3 | 38.0 | 고평가 | |
| EV / Revenue (EV / 매출) | 2.95년 평균 ≈3.7 | ≈3.7 | · | · | |
| EV / FCF | 1508.15년 평균 ≈592.1 | ≈592.1 | · | · | |
| 주가 / 유형 장부 가치 (MRQ) | 3.8 | · | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | AORT | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 매출 총이익률 (TTM) | 64.4%5년 평균 ≈64.8% | ≈64.8% | 64.0% | 동일 | |
| 영업이익률 (TTM) | 4.4%5년 평균 ≈4.8% | ≈4.8% | -7.6% | 동일 | |
| EBITDA 마진 (TTM) | 9.6%5년 평균 ≈11.4% | ≈11.4% | -7.6% | 동일 | |
| 세전 마진 (TTM) | 0.47%5년 평균 ≈-2.9% | ≈-2.9% | -8.7% | 동일 | |
| 순이익률 (TTM) | -0.67%5년 평균 ≈-4.2% | ≈-4.2% | -9.5% | 동일 | |
| ROA (TTM) | -0.33%5년 평균 ≈-1.8% | ≈-1.8% | -20.2% | 최상위권 | |
| ROE (TTM) | -0.73%5년 평균 ≈-5.1% | ≈-5.1% | -25.1% | 최상위권 | |
| ROIC | 3.4%5년 평균 ≈3.8% | ≈3.8% | -31.3% | 최상위권 |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | AORT | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 (MRQ) | 0.85년 평균 ≈1.0 | ≈1.0 | 0.6 | 높은 부채 | |
| 유동비율 (MRQ) | 3.55년 평균 ≈4.6 | ≈4.6 | 5.6 | 낮은 유동성 | |
| Quick Ratio (당좌 비율) | 1.55년 평균 ≈2.0 | ≈2.0 | 3.6 | 낮은 유동성 | |
| 장기 부채 / 자기 자본 (MRQ) | 0.85년 평균 ≈1.0 | ≈1.0 | 0.6 | 높은 부채 |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | AORT | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | 13.6%5년 평균 ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | 12.0%5년 평균 ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 11.8% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | AORT | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 0.55년 평균 ≈0.5 | ≈0.5 | 0.5 | 동일 | |
| Inventory Turnover (재고 회전율) | 1.85년 평균 ≈1.6 | ≈1.6 | 1.8 | 동일 | |
| Receivables Turnover (매출 채권 회전율) | 5.25년 평균 ≈5.4 | ≈5.4 | 6.9 | 약함 | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$245.2K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
연간 지급액≈$0.12
| 배당락일 | 금액 | 통화 | 수익률 |
|---|---|---|---|
| 12월 9, 2015 | $0.03 | USD | ≈1.2% |
| 9월 9, 2015 | $0.03 | USD | ≈1.2% |
| 6월 10, 2015 | $0.03 | USD | ≈1.1% |
| 3월 11, 2015 | $0.03 | USD | ≈1.2% |
| 12월 10, 2014 | $0.03 | USD | ≈1.1% |
| 9월 10, 2014 | $0.03 | USD | ≈1.2% |
| 6월 11, 2014 | $0.03 | USD | ≈1.3% |
| 3월 12, 2014 | $0.03 | USD | ≈1.2% |
| 12월 11, 2013 | $0.03 | USD | ≈1.1% |
| 9월 11, 2013 | $0.03 | USD | ≈1.7% |
| 6월 12, 2013 | $0.03 | USD | ≈1.7% |
| 3월 12, 2013 | $0.03 | USD | ≈1.2% |
| 12월 12, 2012 | $0.03 | USD | ≈0.83% |
| 9월 12, 2012 | $0.03 | USD | ≈0.45% |
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-518.1%
다음 실적
11월 04, 2026
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 8월 5, 2026 | $-0.28 | $0.01 | -2845.1% |
| 2026년 3월 31일 | $0.03 | $0.05 | -40.1% | |
| 2025년 12월 31일 | $0.05 | $0.08 | -40.0% | |
| 2025년 9월 30일 | $0.06 | $0.02 | 242.9% | |
| 2025년 6월 30일 | $0.08 | $-0.00 | — | |
| 2025년 3월 31일 | $-0.01 | $-0.12 | 91.7% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
대차대조표
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
현금 흐름
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
수익성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
유동성 및 지급능력
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
효율성
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
주당
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.09 | $6.36 | $6.62 | $6.80 | $7.26 | $8.14 | $7.32 | $7.15 | $7.37 | $6.11 | · | $5.09 | |
| Revenue / Share | $9.36 | $9.32 | $8.69 | $7.84 | $7.67 | $6.69 | $7.30 | $7.22 | $5.55 | $5.50 | · | $5.11 | |
| Cash Flow / Share | $0.85 | $0.53 | $0.46 | $-0.13 | $-0.07 | $0.33 | $0.42 | $0.27 | $0.32 | $0.60 | · | $0.29 | |
| Cash / Share | $1.32 | $1.23 | $1.38 | $0.94 | $1.33 | $1.52 | $0.87 | $1.08 | $1.06 | $1.65 | · | $1.14 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.12 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.12 | $0.12 | |
| EPS (TTM) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 |
성장률
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
손익계산서
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | · | 47,233,000 | 44,296,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 41,290,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | · | 48,775,000 | 45,378,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 47,886,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
대차대조표
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
현금 흐름
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
수익성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
유동성 및 지급능력
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
효율성
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
주당
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.88 | $9.01 | · | $8.98 | $8.64 | $6.66 | · | $7.02 | · | · | · | $6.39 | $6.66 | $6.61 | · | $6.10 | |
| Revenue / Share | $2.59 | $2.34 | · | $2.32 | $2.49 | $2.34 | · | $2.29 | $2.35 | $2.03 | · | $2.15 | $2.19 | $2.06 | · | $1.92 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $-0.40 | · | · | · | $-0.11 | · | · | · | $-0.15 | · | · | |
| Cash / Share | $1.54 | $1.12 | · | $1.50 | $1.10 | $0.85 | · | $1.29 | · | · | · | $1.26 | $1.15 | $0.73 | · | $0.90 | |
| EPS (TTM) | $-0.06 | $0.25 | · | $-0.25 | $-0.43 | $-0.51 | · | $-0.02 | $-0.21 | $-0.24 | · | $-0.60 | $-0.70 | $-0.73 | · | $-1.03 |
가치 평가 (TTM)
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $471M | $459M | · | $423M | $405M | $390M | · | $385M | $377M | $368M | · | $340M | $329M | $320M | · | $314M | |
| Net Income TTM | $-3M | $12M | · | $-9M | $-18M | $-21M | · | $-851.0K | $-8M | $-10M | · | $-25M | $-28M | $-29M | · | $-41M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -374.5 | 146.5 | · | -169.4 | -72.3 | -48.2 | · | -1331.0 | -122.1 | -88.2 | · | -25.3 | -24.6 | -17.9 | · | -13.4 | |
| P/S | 2.4 | 4.0 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.8 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| EV / Revenue | 3.0 | 4.3 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.6 | 3.0 | 2.6 | · | 2.7 | |
| Dividend Yield | 0.30% | 0.19% | · | 0.16% | 0.23% | 0.31% | · | 0.30% | · | · | · | 0.53% | 0.47% | 0.61% | · | 0.59% | |
| Earnings Yield | -0.27% | 0.68% | · | -0.59% | -1.4% | -2.1% | · | -0.08% | -0.82% | -1.1% | · | -4.0% | -4.1% | -5.6% | · | -7.4% | |
| Annual Payout | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 매출 | $441M | $389M | $354M | $314M | $299M |
| 매출 총이익률 % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| 영업이익률 % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| 순이익 | $10M | $-13M | $-31M | $-19M | $-15M |
| 희석 EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| 유동비율 | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| 당좌 비율 | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
| 지표 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $839.0K | $11M | $11M | $-14M | $-16M |
기관 투자자 (13F) 212개의 제출자 · $1.2B 전체 · 기준일 2026년 9월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
보유자
212
보유 가치
$1.2B
신규 포지션
34
청산 포지션
65
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 34 (-7 이전 분기 대비) | 65 (+29 이전 분기 대비) | 81 (-12 이전 분기 대비) | 56 (-7 이전 분기 대비) | +2.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| BlackRock, Inc. | $149,965,153 | 6,674,017 | 12.78% | 주식 |
| VANGUARD GROUP INC | $144,587,760 | 3,170,089 | 12.33% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71,566,000 | 3,184,974 | 6.10% | 주식 |
| MORGAN STANLEY | $57,477,400 | 2,557,961 | 4.90% | 주식 |
| Juniper Investment Company, LLC | $45,386,816 | 2,019,885 | 3.87% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,043,789 | 2,004,619 | 3.84% | 주식 |
| FMR LLC | $44,119,203 | 1,963,471 | 3.76% | 주식 |
| STATE STREET CORP | $41,750,406 | 1,858,051 | 3.56% | 주식 |
| Ophir Asset Management Pty Ltd | $40,446,180 | 1,800,008 | 3.45% | 주식 |
| PERCEPTIVE ADVISORS LLC | $39,036,906 | 1,737,290 | 3.33% | 주식 |
| Conestoga Capital Advisors, LLC | $36,484,539 | 1,623,700 | 3.11% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $28,318,470 | 1,260,279 | 2.41% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $25,043,403 | 1,114,297 | 2.13% | 주식 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23,011,325 | 1,024,091 | 1.96% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22,205,281 | 988,219 | 1.89% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $21,300,127 | 947,941 | 1.82% | 주식 |
| CITADEL ADVISORS LLC | $18,596,037 | 827,594 | 1.59% | 주식 |
| YARGER WEALTH STRATEGIES, LLC | $15,278,432 | 634,223 | 1.30% | 주식 |
| ROYCE & ASSOCIATES LP | $14,364,667 | 639,282 | 1.22% | 주식 |
| NORTHERN TRUST CORP | $12,370,454 | 550,532 | 1.05% | 주식 |
| BANK OF AMERICA CORP /DE/ | $11,716,689 | 521,437 | 1.00% | 주식 |
| Qube Research & Technologies Ltd | $10,704,820 | 476,405 | 0.91% | 주식 |
| FRED ALGER MANAGEMENT, LLC | $10,406,104 | 463,111 | 0.89% | 주식 |
| UBS Group AG | $10,210,390 | 454,401 | 0.87% | 주식 |
| TWO SIGMA ADVISERS, LP | $9,974,907 | 218,700 | 0.85% | 주식 |
| Invesco Ltd. | $9,956,839 | 443,117 | 0.85% | 주식 |
| GOLDMAN SACHS GROUP INC | $9,857,903 | 438,714 | 0.84% | 주식 |
| D. E. Shaw & Co., Inc. | $9,846,714 | 438,216 | 0.84% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,183,579 | 408,704 | 0.78% | 주식 |
| Toroso Investments, LLC | $9,018,146 | 197,723 | 0.77% | 주식 |
| Soleus Capital Management, L.P. | $8,718,360 | 388,000 | 0.74% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $8,702,159 | 387,279 | 0.74% | 주식 |
| Balyasny Asset Management L.P. | $8,584,686 | 382,051 | 0.73% | 주식 |
| First Eagle Investment Management, LLC | $7,787,496 | 346,573 | 0.66% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $6,978,103 | 310,552 | 0.59% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $6,611,371 | 294,231 | 0.56% | 주식 |
| Legal & General Group Plc | $5,826,427 | 259,298 | 0.50% | 주식 |
| WASATCH ADVISORS LP | $5,726,929 | 156,388 | 0.49% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $5,705,178 | 253,902 | 0.49% | 주식 |
| Bank of New York Mellon Corp | $5,671,109 | 252,386 | 0.48% | 주식 |
| Quantinno Capital Management LP | $4,497,191 | 200,142 | 0.38% | 주식 |
| AMERIPRISE FINANCIAL INC | $4,348,978 | 193,546 | 0.37% | 주식 |
| FIFTH THIRD BANCORP | $4,170,912 | 185,621 | 0.36% | 주식 |
| ORBIMED ADVISORS LLC | $3,932,250 | 175,000 | 0.34% | 주식 |
| Corient Private Wealth LP | $3,580,552 | 159,348 | 0.31% | 주식 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3,324,253 | 90,777 | 0.28% | 주식 |
| Public Sector Pension Investment Board | $3,298,304 | 146,787 | 0.28% | 주식 |
| Parkman Healthcare Partners LLC | $3,121,982 | 138,940 | 0.27% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2,879,149 | 128,133 | 0.25% | 주식 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2,857,263 | 127,159 | 0.24% | 주식 |
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 제출 서류 | 2025년 8월 12일 | 4.00% | 수정본 | · | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 2011년 5월 11일 | · | 최초 제출 | M&A / 매각 | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 2007년 7월 10일 | · | 최초 제출 | · | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2005년 12월 2일 | · | 최초 제출 | 수동적 투자 | SEC |
| 미공개 보고자 | 2005년 3월 18일 | · | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
회사 내부자 49 명의 내부자 · 30 임원 · 15 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 2026년 8월 19일 S | 877,275 | 0 | 9 | $-9,722,946 |
| Lance A Berry | EVP, COO, CFO & Treasurer | 2026년 8월 14일 S | 210,112 | 0 | 5 | $-803,205 |
| David Ashley Lee | Executive VP, COO & CFO | 2023년 3월 2일 S | 347,217 | 0 | 0 | $0 |
| Andrew M Green | SVP, Regulatory and Quality | 2026년 9월 10일 S | 40,160 | 0 | 6 | $-1,431,215 |
| Jean F Holloway | SVP, General Counsel | 2026년 8월 12일 S | 184,118 | 0 | 13 | $-2,537,794 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 2026년 3월 3일 S | 60,097 | 0 | 13 | $-3,426,956 |
| John E Davis | Chief Commercial Officer | 2026년 3월 3일 S | 230,794 | 0 | 9 | $-1,745,924 |
| Amy Horton | VP, Chief Accounting Officer | 2026년 3월 3일 S | 139,088 | 0 | 8 | $-870,080 |
| Matthew A Getz | VP, Human Resources | 2024년 8월 16일 S | 34,116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 2024년 2월 27일 S | 21,558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 2024년 2월 26일 S | 44,518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 2024년 2월 23일 A | 13,291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 2023년 6월 6일 S | 34,724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 2022년 11월 8일 A | 32,516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 2021년 3월 12일 F | 153,203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 2019년 3월 14일 F | 30,806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 2019년 3월 14일 F | 25,084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 2018년 3월 5일 F | 39,883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 2017년 11월 16일 M | 77,135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 2015년 4월 9일 F | 1,271,846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 2015년 3월 7일 F | 42,106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 2015년 3월 7일 F | 110,559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 2015년 2월 26일 A | 73,441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 2014년 8월 15일 M | 95,221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 2012년 11월 30일 S | 71,999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 2011년 12월 31일 F | 110,144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 2007년 9월 4일 A | 23,100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 2006년 1월 18일 M | 42,728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 2004년 9월 21일 M | 55,131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 2004년 9월 14일 M | 36,165 | 0 | 0 | $0 |
| Anthony B. Semedo | 이사 | 2026년 6월 2일 J | 6,325 | 0 | 0 | $0 |
| Elizabeth A Hoff | 이사 | 2026년 5월 18일 A | 34,765 | 0 | 1 | $-189,420 |
| Marna P Borgstrom | 이사 | 2026년 5월 18일 A | 56,664 | 0 | 0 | $0 |
| Jon W Salveson | 이사 | 2026년 5월 18일 A | 137,416 | 0 | 0 | $0 |
| Jeffrey H Burbank | 이사 | 2026년 5월 18일 A | 61,372 | 0 | 0 | $0 |
| Daniel J Bevevino | 이사 | 2026년 5월 18일 A | 157,637 | 0 | 0 | $0 |
| Bullock James | 이사 | 2026년 5월 18일 A | 76,223 | 0 | 0 | $0 |
| Thomas F Ackerman | 이사 | 2026년 5월 18일 A | 157,472 | 0 | 0 | $0 |
| Harvey Morgan | 이사 | 2021년 8월 30일 G | 46,342 | 0 | 0 | $0 |
| Ronald D Mccall | 이사 | 2021년 8월 25일 S | 121,768 | 0 | 0 | $0 |
| Elkins C Ronald | 이사 | 2018년 9월 5일 S | 64,843 | 0 | 0 | $0 |
| James Benson | 이사 | 2017년 10월 2일 S | 54,086 | 0 | 0 | $0 |
| John M Cook | 이사 | 2009년 6월 9일 M | 85,000 | 0 | 0 | $0 |
| LACY VIRGINIA C | 이사 | 2007년 4월 24일 S | 255,280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | 이사 | 2006년 8월 1일 A | 12,800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | 10% 소유주 | 2007년 5월 31일 S | 1,918,000 | 0 | 0 | $0 |
| Michael S Simpson | · | 2021년 3월 5일 F | 33,698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | · | 2020년 5월 5일 A | 23,451 | 0 | 0 | $0 |
| Thomas J Lynch | · | 2004년 11월 2일 A | 5,000 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 36 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.64% | 42,246 NS | 2026년 7월 31일 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.59% | 46,432 SH | 2026년 10월 2일 | 일간 |
| RZG · Invesco Exchange-Traded Fund Trust | 0.40% | 21,951 SH | 2026년 10월 2일 | 일간 |
| EBIT · Harbor ETF Trust | 0.25% | 1,133 NS | 2026년 7월 31일 | N-PORT |
| ESSC · Strategy Shares | 0.17% | 2,304 NS | 2026년 7월 31일 | N-PORT |
| IHI · iShares Trust | 0.16% | 203,954 SH | 2026년 9월 11일 | 일간 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.10% | 50,848 SH | 2026년 8월 19일 | 일간 |
| IWO · iShares Trust | 0.07% | 429,440 SH | 2026년 9월 11일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 49,054 SH | 2026년 8월 19일 | 일간 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.05% | 148,966 SH | 2026년 8월 19일 | 일간 |
| RSSL · Global X Funds | 0.04% | 21,860 NS | 2026년 7월 31일 | N-PORT |
| ISCG · iShares Trust | 0.04% | 14,453 SH | 2026년 9월 11일 | 일간 |
| IWM · iShares Trust | 0.04% | 1,164,969 SH | 2026년 9월 11일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 263,046 SH | 2026년 8월 19일 | 일간 |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.03% | 23,979 SH | 2026년 10월 2일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 30,302 SH | 2026년 10월 2일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.02% | 124,676 NS | 2026년 7월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 20,435 NS | 2026년 7월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 495,296 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 127,662 SH | 2026년 8월 19일 | 일간 |
| WSML · iShares Trust | 0.01% | 2,287 SH | 2026년 9월 11일 | 일간 |
| DXUV · Dimensional ETF Trust | 0.01% | 1,400 NS | 2026년 7월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 90,038 NS | 2026년 7월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 3,634 NS | 2026년 7월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,761 NS | 2026년 7월 31일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9,530 NS | 2026년 7월 31일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13,831 NS | 2026년 7월 31일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 61,878 SH | 2026년 9월 11일 | 일간 |
| IWV · iShares Trust | 0.00% | 10,858 SH | 2026년 9월 11일 | 일간 |
| DFAT · Dimensional ETF Trust | 0.00% | 2,692 NS | 2026년 7월 31일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,463,340 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,652 SH | 2026년 8월 19일 | 일간 |
| IJR · iShares Trust | · | 2,603,782 SH | 2026년 9월 10일 | 일간 |
| IJT · iShares Trust | · | 403,685 SH | 2026년 9월 9일 | 일간 |
| XJR · iShares Trust | · | 5,899 SH | 2026년 9월 2일 | 일간 |
| ISCB · iShares Trust | · | 2,111 SH | 2026년 9월 11일 | 일간 |
AORT 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
평점 · 14 명의 애널리스트
매수
중앙값 목표
$42.00
+88.3%
5 35.7%
적극 매수
8 57.1%
매수
1 7.1%
보유
0 0.0%
매도
0 0.0%
적극 매도
12개월 목표 주가
8 명의 애널리스트 · 2026-09-29평균 목표 $42.15 +88.9%
← 모든 목표가 하회
현재가 $22.31
저가$38.00
평균$42.15
고가$48.00
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
출처: SEC 10-Q 제출 8월 7, 2026